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PBB Inhibits Metabolic Cooperation in
Chinese Hamster Cells in Vitro: Its
Potential as a Tumor Promoter
by James E. Trosko,* B. Dawson,* and C.-C. Chang*
Using an in vitro assay system, polybrominated biphenyl (PBB) was assessed for its ability to
inhibit metabolic cooperation between 6-thioguanine sensitive and resistant Chinese hamster
V79 cells. Using a nonlethal range of the chemical, PBB was shown to inhibit metabolic
cooperation (a form of cell-cell communication) in a manner similar to other known tumor
promoters. Results suggest that PBB could
carcinogenic promoter.
Introduction
Carcinogenesis in many animal test systems has
been shown to be a complex and multistaged
process (1), consisting of initiation and promotion
phases (2, 3). Not only has this initiation/promotion
concept of carcinogenesis been found in vivo in
animals, but also it appears to explain the multi-
step processes of in vitro transformation (4-6).
Moreover, there are several reports which can lead
one to believe that initiation and promotion phases
exist in human carcinogenesis (7-11).
Initiation is now thought to involve the induction
of DNA damage and the error-prone repair or
replication ofthat damage in mutation fixation (12),
whereas promotion seems to be the selective prolif-
eration of the initiated cells by agents that affect
cell membranes (i.e., tumor promoters) (13-17)
Yotti et al. (18), Trosko et al. (19), and Murray
and Fitzgerald (20) have shown that known tumor
promoters blocked metabolic cooperation between
cells in vitro. Although the mechanism by which
tumor promoters block this form of cell-cell com-
munication is not known, it is suspected that
interference with gap-junction function (21) might
be involved (18, 20). Once cells escape the contact-
inhibiting (22) or chalone-inhibiting function of
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act, epigenetically, as a teratogen and a
other neighboring cells (23-28), they can start
proliferating.
The widespread exposure of the human popula-
tion ofMichigan to polybrominated biphenyl (PBB)
by an accidental contamination of animal feed (29)
has promoted a widespread number of studies on
the potential biological consequences on human
health. We report the results ofour studies to test
ifPBB acts as other known tumor promoters in our
in vitro assay using Chinese hamster cells.
Materials and Method
All cells used in the assay were originally derived
from V79 Chinese hamster lung cells. The detailed
protocol for the in vitro promoter assay has been
reported(19). Wild-typecells[6-thioguanine-sensitive,
presumptive hypoxanthine guanine-phosphoribosyl-
transferase (HG-PRT+)] are seeded into 100 mm
tissue culture dishes at a density of9x105 cells per
dish. Immediately after plating of wild-type cells,
100 6-thioguanine-resistant cells (HG-PRT-) are
seeded in the same dishes. Both cell lines are given
4 hr for attachment, at which time the PBB
(Velsicol Corp.; dissolved in acetone) is added
directly into each individual dish. 6-Thioguanine
(final concentration, 10 ,ug/ml) was added immedi-
ately after treatment with PBB. The cells were
incubated for two days without interruption, at
whichtimethemediumwaschanged. PBB-eontaining
medium was removed and growth continued on the
179selective medium. Afteranothertwo days ofgrowth,
the medium was again replaced with fresh selective
medium. Three more days of growth resulted in
colonies of a size sufficient to score visually. The
medium is decanted, each dish was rinsed with
0.85% saline; the plates were air-dried, fixed with
95% ethanol and stained with Giemsa. The result-
ing colonies were scored visually.
Results and Discussion
In order to determine the cytotoxicity of PBB,
the experiment in Figure 1 was performed. The
colony-forming ability of V79 cells was measured
after continuous exposure, during their growth, to
increasing concentrations of PBB. We, then, per-
formed a preliminary experiment using the highest
concentration of PBB which had little lethal effect
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FIGURE 1. Colony-forming ability of Chinese hamster (V79)
cells in increasing concentration of PBB. The data are
expressed as the percentage of plated cells which formed
colonies when 200 cells were plated in four plates for
each group. PBB was prepared by serial dilution in
concentration such that lOOX of PBB was added to each
plate.
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on colony-forming ability, to determine if PBB
would inhibit metabolic cooperation between
6-thioguanine sensitive and resistant cells (Table
1). The results clearly indicate that PBB, although
not as effective as 12-o-tetradecanoyl phorbol-13-
acetate (TPA; an internal control promoter), did
inhibit metabolic cooperation.
As an extension of these results, we designed a
dose-response experiment. Figure 2 demonstrates
that there does seem to be a definite dose response
curve from 2.5 ,ug/ml to 10 ,ug/ml. The data also
suggest a threshold level, below which no inhibition
ofmetabolic cooperation is detectable. It must also
be stressed that the inhibition ofmetabolic coopera-
tion that was observed was at levels which were
nontoxic to the cells.
Ifwe assume that carcinogenesis in human beings
consists of initiation and promotion phases, that
this in vitro assay to detect tumor promoters, using
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FIGURE 2. Dose-response curve for the effect of PBB on the
inhibition of metabolic cooperation between HG-PRT + and
HG-PRT- Chinese hamster V79 cells. The shaded areas
correspond tothe mean recoveryofHG-PRT-colonies forthe
control and TPA-treated groups ± SD. The data are expres-
sed as the percentage of HG-PRT- cells which forrnecl
colonies inthe presence ofHG-PRT + cellsusing21 plates for
each group.
Environmental Health PerspectivesTable 1. Recovery of 6TGR Cells in the presence of TPA and PBB.a
V79 (HG-PRT+), 6TGR (HG-PRT-), Concentration, Recovery,
cells/plate cells/plate Drug ,g/ml %
9 x 105 100 - 24.0 0.8
9 x 105 100 TPA 0.1 ,ug/ml 90.2 1.8b
9 x 105 100 PBB 7.5 ,ug/ml 38.7 1.5b
aTPA = 12-a-tetradecanoylphorbol-13-acetate (dissolved in 100% ethanol); PBB = Firemaster Bp-6 (dissolved in acetone).
bTreatment significantly increased the % recovery above control according to the Student-Newman-Keuls' (SNK) Test (p < 0.01)
Chinese hamster lung cells, is relevant to the
human situation, and that blocking of metabolic
cooperation (as a marker for cell-cell communica-
tion) is a property ofall tumor promoters, then we
feel that PBB has the properties of a potential
tumor promoter. Since all three of the former
assumptions have yet to be rigorously verified, we
cannot conclude that PBB is a definite tumor
promoter for human beings. However, because of
the general similarity ofcarcinogenesis in all mam-
mals and the general (but by no means) concurrence
ofin vitro and in vivo tests for carcinogenicity, one
would predict PBB could be a tumor promoter.
PBB has been shown to reduce, significantly, the
incidence of N-2-fluorenylacetamide-induced mam-
mary gland and ear duct tumors in female rats (30).
Of importance is the observation that PBB has
many properties similar to phenobarbital (31, 32)
and butylated hydroxytoluene (31-34), in that these
chemicals can inhibit chemically induced carcinog-
enesis if administered prior to the carcinogen, but
they act as promoters when given after carcinogen
exposure. These observations in animals, plus our
in vitro results, lead us to believe that, i7l vivo,
PBB could be a promoter ofcertain types oftumors
under conditions where the organism has been
previously initiated.
Furthermore, because of a recent in vitro assay
for teratogens which is based on the ability of a
chemical to affect cell membrane surface adhesion
(35), one might predict PBB could also be a teratog-
en. Since both our assay and the teratogen assay
are dependent on specific membrane components,
not all cells in all organs will be negatively affected
by PBB (or any other chemical). However, this
demonstration that PBB does affect a cell type, in a
manner similar to a wide number of other known
promoters (i.e., saccharin, DDT, Tween 60, pheno-
barbital, etc.) (19), forms the basis for additional
experiments, in animals, to verify both the promo-
tion and teratogen potential of PBB.
This research was supported by a NCI grant (CA 21104), a
MSU All-University Grant (80-37), a MSU Agriculture Experi-
ment Station Grant, a MSU Toxicology Center grant, and a
MSU College of Human Medicine grant to J.E.T. (CA 21104)
and a NIEHS Young Environmental Scientists Award to C.-C.
Chang (ES 01809).
REFERENCES
1. Slaga, T. J., Sivak, A., and Boutwell, R. K., Eds. Carcinog-
enesis, Vol. 2, Raven Press, New York, 1978.
2. Berenblum, I. A speculative review: The probable nature of
promoting action and its significance in the understanding of
the mechanism of carcinogenesis. Cancer Res. 14: 471
(1954).
3. Boutwell, R. K. The biochemistry of preneoplasia in mouse
skin. Cancer Res. 35: 2631 (1976).
4. Mondal, S., Brankow, D. W., and Heidelberger. C. Two-
stage chemical oncogenesis in cultures of C3H/1OT ½/2 cells.
Cancer Res. 36: 2254 (1976).
5. Mondal, S., and Heidelberger, C. Transformation of
C3H/1OT 1/2 CL8 mouse embryo fibroblasts by ultraviolet
irradiation and a phorbol ester. Nature 260: 710 (1976).
6. Kennedy, A. R., Mondal, S., Heidelberger, C., and Little,
J. B. Enhancement of x-radiation transformation by a
phorbol ester using C3H/1OT1/2 CL8 mouse embryo fibro-
blast. Cancer Res. 38: 438 (1978).
7. Reddy, B. S., Weisburger, J. H., and Wynder, E. L. Colon
cancer: bile salts as tumor promoters, In: Carcinogenesis,
Vol. 2, T. J. Slaga, A. Sivak, and R. K. Boutwell, Eds.,
Raven Press, New York, 1978, p. 453.
8. Weber, J., and Hecker, E. Experimentia 34: 679 (1978).
9. Weiss, W. Changing incidence of thyroid cancer. J. Natl.
Cancer Inst. 62: 1137 (1979).
10. Domellof, L. Gastric carcinoma promoted by alkaline reflux
gastritis with special reference to bile and other surfactants
as promoters ofpost operative gastric cancer. Med. Hypoth.
5: 463 (1979).
11. Oscarson, J. E. A., Veen, H. G., Ross, J. S., and Malt,
R. A. Illeal resection potentiates 1,2-dimethylhydrazine-
induced colonic carcinogenesis. Ann. Surgery 189: 503
(1979).
12. Trosko, J. E., and Chang, C.-C. The role of radiation an(d
chemicals in the induction of mutations and epigenetic
changes during carcinogenesis. In: Advances in Radiation
Biology, Vol. 9, J. Lett and H. Adler, Eds., Academic
Press, New York, in press.
13. Sivak, A., and Van Durren, B. L. Cellular interactions of
phorbol myristate acetate in tumor promotion. Chem. Biol.
Interact. 3: 401 (1971).
14. Wenner, C. E.. Hackney, J., Kimelberg. H. K.. and
Mayhew, E. Membrane effects of phorbol esters. Cancer
Res. 34: 1731 (1974).
15. Blumberg, P. M., Driedger, P. E., and Rossow, P. W.
Effect of a phorbol ester on a transformation sensitive
surface protein ofchick fibroblasts. Nature 264: 446 (1976).
16. Horton, A. W., Eshlemon, D. N., Schuff. A. R.. an(d
January 1981 181Perman, W. H. Correlation of carcinogenic activity among
n-alkanes with theirphysical effects onphospholipid micells.
J. Natl. Cancer Inst. 56: 387 (1979).
17. Shoyab, M., Delarco, J. E., and Todaro, G. H. Biologically
active phorbol esters specifically alter affinity of epidermal
growth factor membrane receptors. Nature 279: 387 (1979).
18. Yotti, L. P., Chang, C.-C., and Trosko, J. E. Elimination of
metabolic cooperation in Chinese hamster cells by a tumor
promoter. Science 206: 1089 (1979).
19. Trosko, J. E., Yotti, L. P., Dawson, B., and Chang, C.-C.
In Vitro assay for tumor promoters. In: Short Term Tests
for Chemical Carcinogens, H. Stich and R. H. C. San,
Eds., Springer-Verlag, New York, in press.
20. Murray, A. W., and Fitzgerald, D. H. Tumor promoters
inhibit metabolic cooperation in cocultures ofepidermal and
3T3 cells. Biochem. Biophys. Res. Commun. 91: 395 (1979).
21. Loewenstein, W. R. Junctional intercellular communication
and the control of growth. Biochim. Biophys. Acta 580: 1
(1979).
22. Levine, E. M.. Becker, Y., Boone, C. W.. and Eagle, H.
Contact inhibition macromolecular synthesis and polyribos-
omes in cultured human diploid fibroblasts. Proc. Natl.
Acad. Sci. (U.S.) 53: 350 (1965).
23. Bullough, W. S. Mitotic and functional homeostasis: a
speculative review. Cancer Res. 25: 1683 (1965).
24. Krig, L., Kulhmann, I., and Marks, F. Effect of tumor-
promoting phorbol esters and of acetic acid on mechanisms
controlling DNA synthesis and mitosis (Chalones) and on
the biosynthesis of histidine-rich protein in mouse epider-
mis. Cancer Res. 34: 3135 (1974).
25. Houck, J. C., Chalones. American Elsevier, New York,
1976.
26. Bell, G. I. Model ofcarcinogenesis as an escape from mitotic
inhibitors. Science 192: 569 (1976).
27. Onda, H. A new hypothesis on mitotic control mechanisms
in eukaryotic cells: Cell-specific mitosis-inhibiting protein
excretion hypothesis. J. Theor. Biol. 77: 367 (1979).
28. Gilbert, D. A. The mechanism of action and interaction of
regulators of cell replication. Biosystems 10: 227 (1978).
29. Carter, L. J. Michigan's PBB incident: Chemical mix-up
leads to disaster. Science 192: 240 (1976).
30. Schwartz, E. L., Kluwe, W. M., Sleight, S. D., Hook, J. B.,
and Goodman, J. I. Inhibition of N-2-fluorenylacetamide-
induced mammary tumorigenesis in rats by dietary poly-
brominated biphenyls. J. Natl. Cancer Inst. 64: 63 (1980).
31. Peraino, C., Fry, R. J., Staffeldt, E. Reduction and
enhancement by phenobarbital of hepatocarcinogenesis in-
duced in the rat by 2-acetylaminofluorine. Cancer Res. 31:
1506 (1971).
32. Peraino, C., Fry, F. J., Staffeldt, E., Christopher, J. P.
Enhancing effects of phenobarbital and butylated hydroxy-
toluene on 2-acetylanino-fluorene-induced hepatic tumorig-
enesis in the rat. Food Cosmet. Toxicol. 15: 93 (1975).
33. Ulland, B. M., Weisburger, J. H., Yamamoto, R. S., And
Weisburger, E. K. Antioxidants and carcinogenesis: Butyl-
ated hydroxytoluene, but not diphenyl-p-phenylenediamine,
inhibits cancer induction by N-2-fluorenylacetamide and by
N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet.
Toxicol. 11: 199 (1973).
34. Goodman, J. I., Trosko, J. E., Yager, J. D., Jr. Studies on
the mechanism ofinhibition of2-acetylaminofluorene toxici-
ty by butylated hydroxytoluene. Chem. Biol. Interact. 12:
171 (1976).
35. Braun, A.G., Emerson, D. J., and Nichinson, B. B. Terat-
ogenic drugs inhibit tumor cell attachment to lectin-coate(l
surfaces. Nature 282: 507 (1979).
182 Environmental Health Perspectives